跳至主要内容
临床试验/NCT03539354
NCT03539354Unknown不适用

TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF)

Meshalkin Research Institute of Pathology of Circulation2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Occurrence of adverse events

研究概览

简要总结

To compare of atrial arrhythmia incidence in patients with coronary artery disease and atrial fibrillation history, undergoing either coronary artery bypass grafting plus temporary spinal cord stimulation or coronary artery bypass grafting alone

详细描述

The study includes 60 patients. Patients are randomized into 2 groups: coronary artery bypass grafting plus b-blocker treatment (according to guidelines; group I) and coronary artery bypass grafting plus b-blocker treatment (according to guidelines) plus temporary spinal cord stimulation (group 2). Temporary spinal cord stimulation is performed for 3 days before surgery and 7 days after coronary artery bypass grafting. Continuous ECG during intensive care unit stay, daily ECG and 24-h Holter monitor recordings at 7, 14, 21, and 30 days after coronary artery bypass grafting, external loop recorder after discharge from intensive care unit until 30 days after coronary artery bypass grafting. Rhythm status and clinical outcome assessment at 12 month follow up

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-80 years;
  • indications for coronary artery bypass grafting according to guidelines;
  • pre-operative history of paroxysmal atrial fibrillation;
  • absent of contraindications for spinal cord stimulation;
  • signed inform consent.

排除标准

  • previous heart surgery or atrial fibrillation ablation procedure;
  • emergency coronary artery bypass grafting;
  • left ventricle ejection fraction <35%;
  • unstable angina or heart failure;
  • persistent atrial fibrillation or atrial fibrillation at the time of screening;
  • planned Maze procedure or pulmonary vein isolation;
  • use of class I or III antiarrhythmic drugs within 5 elimination half-lives of the drug;
  • need for concomitant valve surgery;
  • Inability to control the device for spinal cord stimulation;
  • coagulopathy, immunosuppression, or other condition associated with an unacceptable surgical risk for spinal cord stimulation;
  • Need for therapeutic diathermy in the area of leads placement;
  • Need for pacemaker/ICD/CRT-D implantation;
  • unwillingness to participate.

研究组 & 干预措施

CABG + b-blockers

Active Comparator

Standart coronary artery bypass grafting is performed with b-blockers treatment. Continuous ECG during intensive care unit stay, daily ECG, and 24-h Holter monitor recordings will be performed at 7, 14, 21, and 30 days after coronary artery bypass grafting, external loop recorder after discharge from intensive care unit till 30 days after coronary artery bypass grafting.

干预措施: Coronary artery bypass grafting (Procedure)

CABG + b-blockers

Active Comparator

Standart coronary artery bypass grafting is performed with b-blockers treatment. Continuous ECG during intensive care unit stay, daily ECG, and 24-h Holter monitor recordings will be performed at 7, 14, 21, and 30 days after coronary artery bypass grafting, external loop recorder after discharge from intensive care unit till 30 days after coronary artery bypass grafting.

干预措施: B-blockers (Drug)

CABG + b-blockers + temporary SCS

Experimental

Before coronary artery bypass grafting in the experimental group, 3 days of temporary spinal cord stimulation is performed than device turned off and coronary artery bypass grafting procedure is made. The device for spinal cord is turned on in intensive care unit for 7 days. Continuous ECG during intensive care unit stay, daily ECG, and 24-h Holter monitor recordings will be performed at 7, 14, 21, and 30 days after coronary artery bypass grafting, external loop recorder after discharge from intensive care unit till 30 days after coronary artery bypass grafting.

干预措施: Temporary spinal cord stimulation (Device)

CABG + b-blockers + temporary SCS

Experimental

Before coronary artery bypass grafting in the experimental group, 3 days of temporary spinal cord stimulation is performed than device turned off and coronary artery bypass grafting procedure is made. The device for spinal cord is turned on in intensive care unit for 7 days. Continuous ECG during intensive care unit stay, daily ECG, and 24-h Holter monitor recordings will be performed at 7, 14, 21, and 30 days after coronary artery bypass grafting, external loop recorder after discharge from intensive care unit till 30 days after coronary artery bypass grafting.

干预措施: Coronary artery bypass grafting (Procedure)

CABG + b-blockers + temporary SCS

Experimental

Before coronary artery bypass grafting in the experimental group, 3 days of temporary spinal cord stimulation is performed than device turned off and coronary artery bypass grafting procedure is made. The device for spinal cord is turned on in intensive care unit for 7 days. Continuous ECG during intensive care unit stay, daily ECG, and 24-h Holter monitor recordings will be performed at 7, 14, 21, and 30 days after coronary artery bypass grafting, external loop recorder after discharge from intensive care unit till 30 days after coronary artery bypass grafting.

干预措施: B-blockers (Drug)

结局指标

主要结局

Occurrence of adverse events

时间窗: 30 days

MACE (Death, Stroke/TIA, Myocardial infarction), acute kidney injury, spinal cord injury

Occurrence of atrial tachyarrhythmias

时间窗: 30 days

Occurrence of any atrial tachyarrhythmias including atrial fibrillation, atrial tachycardia, atrial flutter lasting ≥ 30 sec during 30 days after surgery

Occurrence of tachyarrhythmias

时间窗: 12 months

Occurrence of any atrial tachyarrhythmias including atrial fibrillation, atrial tachycardia, atrial flutter lasting ≥ 30 sec 30 days after surgery

次要结局

  • Hemodynamic parameter - Heart rate(30 days)
  • Hemodynamic parameter - Cardiac index(30 days)
  • Renal-replacement therapy(30 days)
  • Acute pain assessment(30 days)
  • Inotropic score(30 days)
  • Duration of mechanical ventilation(30 days)
  • Duration of intensive care unit stay(30 days)
  • Marker of myocardial injury - high-sensitive Troponin I(30 days)
  • Marker of myocardial injury - CK-MB(30 days)
  • Marker of kidney injury - Creatinine(30 days)
  • Hemodynamic parameter - Blood pressure(30 days)
  • Hemodynamic parameter - Vascular resistance(30 days)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验